The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis

Journal of Experimental Medicine

Volumn 202, Issue 8, 2005, Pages 1141-1151

  Chang, Xing ^a   Gao, Jian Xin ^a   Jiang, Qi ^b   Wen, Jing ^a   Seifers, Nick ^b   Su, Lishan ^b   Godfrey, Virginia L ^b   Zuo, Tao ^a   Zheng, Pan ^a   Liu, Yang ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROPATHY; FOX P 3 GENE; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; HEMATOPOIETIC CELL; LETHALITY; MOUSE; MUTATOR GENE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE ACTIVATION; THYMOCYTE; THYMUS ATROPHY;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; BROMODEOXYURIDINE; DNA PRIMERS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; LUCIFERASES; LYMPHATIC DISEASES; MICE; MICE, INBRED BALB C; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS; THYMUS GLAND;

EID: 26844476814     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20050157     Document Type: Article

References (40)

1. Kratz, C.P., T. Niehues, S. Lyding, A. Heusch, G. Janssen, and U. Gobel. 2003. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatr. Hematol. Oncol. 20:167-172.
2. Pelkonen, P., P. Lahdenne, R. Lantto, and V. Honkanen. 2002. Chronic arthritis associated with chromosome deletion 22q11.2 syndrome. J. Rheumatol. 29:2648-2650.
3. Davies, K., E.R. Stiehm, P. Woo, and K.J. Murray. 2001. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J. Rheumatol. 28:2326-2334.
4. Kawamura, T., I. Nimura, M. Hanafusa, R. Fujikawa, M. Okubo, G. Egusa, and M. Amakido. 2000. DiGeorge syndrome with Graves' disease: a case report. Endocr. J. 47:91-95.
5. Sullivan, K.E., D.M. McDonald-McGinn, D.A. Driscoll, C.M. Zmijewski, A.S. Ellabban, L. Reed, B.S. Emanuel, E.H. Zackai, B.H. Athreya, and G. Keenan. 1997. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum. 40:430-436.
6. Davis, S., and M.J. Schumacher. 1979. Myasthenia gravis and lymphoma. A clinical and immunological association. JAMA. 242:2096-2097.
7. Gerli, R., R. Paganelli, A. Cossarizza, C. Muscat, G. Piccolo, D. Barbieri, S. Mariotti, D. Monti, O. Bistoni, E. Raiola, et al. 1999. Longterm immunologic effects of thymectomy in patients with myasthenia gravis. J. Allergy Clin. Immunol. 103:865-872.
8. Bloomfield, S., G. Stockdill, and R.S. Barnetson. 1982. Thymic hypoplasia, auto-immune haemolytic anaemia and juvenile pemphigoid in an infant. Br. J. Dermatol. 106:353-355.
9. MacMurray AJ, DH Moraljo, AE Kwitek, EA Rutledge, B Van Yserloo, P Gohlke, SJ Speros, B Snyder, J Schaefer, S Bieg, et al. 2002. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res. 12:1029-1039.
10. Hornum, L., J. Romer, and H. Markholst. 2002. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes. 51:1972-1979.
11. Brunkow, M.E., E.W. Jeffery, K.A. Hjerrild, B. Paeper, L.B. Clark, S.A. Yasayko, J.E. Wilkinson, D. Galas, S.F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73.
12. Chatila, T.A., F. Blaeser, N. Ho, H.M. Lederman, C. Voulgaropoulos, C. Helms, and A.M. Bowcock. 2000. JM2, encoding a fork headrelated protein, is mutated in X-linked autoimmunity-allergic dysregulation syndrome. J. Clin. Invest. 106:R75-81.
13. Bennett, C.L., J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, L. Whitesell, T.E. Kelly, F.T. Saulsbury, P.F. Chance, and H.D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21.
14. Wildin, R.S., F. Ramsdell, J. Peake, F. Faravelli, J.L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20.
15. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
16. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor FoxP3. Science. 299:1057-1061.
17. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. FoxP3 programs the development and function of CD4CD25 regulatory T cells. Nat. Immunol. 4:330-336.
18. Godfrey, V.L., J.E. Wilkinson, E.M. Rinchik, and L.B. Russell. 1991. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc. Natl. Acad. Sci. USA. 88:5528-5532.
19. Khattri, R., D. Kasprowicz, T. Cox, M. Mortrud, M.W. Appleby, M.E. Brunkow, S.F. Ziegler, and F. Ramsdell. 2001. The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 167:6312-6320.
20. Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell. 66:533-540.
21. Ceredig, R., and T. Rolink. 2002. A positive look at double-negative thymocytes. Nat. Rev. Immunol. 2:888-897.
22. Zuniga-Pflucker, J.C., and M.J. Lenardo. 1996. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8:215-224.
23. von Boehmer, H. 1990. Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol. 8:531-556.
24. Bol, D., K. Kiguchi, L. Beltran, T. Rupp, S. Moats, I. Gimenez-Conti, J. Jorcano, and J. DiGiovanni. 1998. Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. Mol. Carcinog. 21:2-12.
25. Rathmell, J.C., and C.B. Thompson. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 109(Suppl): S97-107.
26. Godfrey, V.L., B.T. Rouse, and J.E. Wilkinson. 1994. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am. J. Pathol. 145:281-286.
27. Farr, A., A. Nelson, J. Truex, and S. Hosier. 1991. Epithelial heterogeneity in the murine thymus: a cell surface glycoprotein expressed by subcapsular and medullary epithelium. J. Histochem. Cytochem. 39:645-653.
28. Rodewald, H.R., K. Kretzschmar, W. Swat, and S. Takeda. 1995. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity. 3:313-319.
29. Scott, G.K., C.H. Chang, K.M. Erny, F. Xu, W.J. Fredericks, F.J. Rauscher, A.D. Thor, and C.C. Benz. 2000. Ets regulation of the erbB2 promoter. Oncogene. 19:6490-6502.
30. Xing, X., S.C. Wang, W. Xia, Y. Zou, R. Shao, K.Y. Kwong, Z. Yu, S. Zhang, S. Miller, L. Huang, and M.C. Hung. 2000. The ets protein PEA3 suppresses ErbB2 overexpression and inhibits tumorigenesis. Nat. Med. 6:189-195.
31. Hurst, H.C. 2001. Update on HER-2 as a target for cancer therapy the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 3:395-398.
32. Martin, S., and M.J. Bevan. 1997. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur. J. Immunol. 27:2726-2736.
33. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988.
34. Chambers, C.A., T.J. Sullivan, and J.P. Allison. 1997. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation- dependent activation of CD4+ T cells. Immunity. 7:885-895.
35. Zheng, X., J.X. Gao, X. Chang, Y. Wang, Y. Liu, J. Wen, H. Zhang, J. Zhang, and P. Zheng. 2004. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus. J. Immunol. 173:2253-2261.
36. Godfrey, V.L., B.T. Rouse, and J.E. Wilkinson. 1994. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am. J. Pathol. 145:281-286.
37. Godfrey, V.L., J.E. Wilkinson, and L.B. Russell. 1991. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138:1379-1387.
38. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341.
39. Sano, S., Y. Takahama, T. Sugawara, H. Kosaka, S. Itami, K. Yoshikawa, J. Miyazaki, W. van Ewijk, and J. Takeda. 2001. Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity. 15:261-273.
40. Imyanitov, E.N., K.G. Buslov, E.N. Suspitsin, E. Kuligina, E.V. Belogubova, M.Y. Grigoriev, A.V. Togo, and K.P. Hanson. 2002. Improved reliability of allele-specific PCR. Biotechniques 33:484, 486, 488 passim.